Reach Your Goal Weight. Prescribed. Proven. Private.
Doctor-prescribed GLP-1 weight loss treatments delivered discreetly to your door.
Physicians
Private
Delivery
GLP SP 2mg
Daily dissolvable GLP-1 to curb appetite and drop weight.
- Curbs Appetite
- Daily Dissolvable Tablet
- Steady, Lasting Results
GLP T 3mg
Dual-action GLP-1 for stronger appetite control.
- Dual-Action Formula
- Daily Dissolvable Tablet
- Maximum Appetite Control
Berberine with Ceylon Cinnamon
Natural metabolic support for blood sugar and weight.
- Supports Healthy Metabolism
- Balances Blood Sugar
- Once-Daily Tablet
Whether you’re a long-time researcher of GLP-1 medications or just starting your journey, the landscape of weight management changed significantly at the end of last year. For a long time, if you wanted the benefits of Wegovy, you had to be okay with a weekly needle.
As of this writing, that’s no longer the case. With the FDA’s recent approval of the Wegovy tablet, you now have a choice between a daily pill and a weekly shot. But while the active ingredient is the same, the experience of taking them is quite different.
Here’s what you need to know to make your decision.
What Is Wegovy?
Wegovy is a brand-name medication containing the active ingredient semaglutide. It belongs to a class of drugs known as GLP-1 receptor agonists, which mimic a hormone naturally found in your body to regulate appetite and digestion.
By signaling to your brain that you’re full and slowing down how quickly your stomach empties, Wegovy helps people with obesity or weight-related health issues lose significant weight when paired with lifestyle changes.
To learn more about GLP-1s and how they work, read How Do GLP‑1 Weight Loss Medications Work? A Simple Patient Guide.
The Arrival of the Wegovy Tablet
For most of the drug’s history, the answer to whether it came as a pill was simply “no”. That changed in December 2025, when the FDA approved the Wegovy pill as the first oral GLP-1 specifically for chronic weight management.
Before this, the only oral semaglutide was Rybelsus, but it was only approved for type 2 diabetes and at much lower doses than what is needed for weight loss. Now, patients have access to a 25 milligram Wegovy tablet taken once daily.
How Oral Semaglutide (Wegovy) Works
The challenge with turning Wegovy into a pill is that semaglutide is a peptide, which your stomach normally digests before it can be absorbed. While an injection bypasses the gut so that nearly 100% is available for the body to use, a pill has to survive stomach acid and enzymes.
How the SNAC enhancer works
To overcome this, the Wegovy pill is co-formulated with sodium N-(8-[2-hydroxylbenzoyl] amino) caprylate (SNAC), an absorption enhancer that helps the drug pass through the stomach lining. Even with this SNAC technology, only about 0.4% to 1% of the drug actually enters the bloodstream.
Why the pill dose is so much higher
This efficiency gap explains why the dosage numbers seem so different. The daily 25 milligram tablet is designed to provide the same systemic drug exposure as the weekly 2.4 milligram injection.
The disparity reflects the difficulty of getting a peptide through the stomach wall, not a difference in the drug’s actual potency.
What the Weight Loss Data Shows
If you’re worried a pill might be less effective, the clinical trials tell a very positive story. In the STEP 1 trial, the weekly injection produced an average weight loss of 14.9% over 68 weeks. The oral versions have shown remarkably similar numbers:
- Oral semaglutide 50 milligram (studied in the OASIS 1 trial) led to a 15.1% average weight reduction over 68 weeks.
- The 25 milligram Wegovy pill (studied in OASIS 4) showed a mean weight reduction of 13.6% at 64 weeks.
- In the OASIS 4 study, over 76% of participants achieved at least 5% body weight loss.
Practical Differences: The Daily Reality
Choosing between the two often comes down to your lifestyle and your tolerance for needles.
The routine
- The injection: You take it once a week. You don’t need to worry about when you last ate or what time it is. It does, however, need to be kept in the refrigerator.
- The tablet: This requires a strict morning ritual. You must take it on an empty stomach with no more than four ounces of plain water, then wait 30 minutes before eating, drinking, or taking other meds. Even a small snack can ruin the absorption. On the plus side, it’s shelf-stable and doesn’t need a fridge.
The cost
Interestingly, the Wegovy pill has launched with a competitive price point. Novo Nordisk priced the tablet at approximately $149 per month without insurance, while the injection typically carries a much higher list price.
Side Effects
Both forms can cause “stomach “flu-like” symptoms—nausea, diarrhea, and vomiting are the most common. Some data suggests these might be slightly more frequent with the oral version, but because the trials were designed differently, it’s hard to make a perfect head-to-head comparison.
Side effects and storage
Both forms share common side effects like nausea, diarrhea, and vomiting. In the OASIS 1 trial, gastrointestinal issues were reported by 80% of those taking the 50 milligram pill.
On the plus side, the tablet is shelf-stable and doesn’t require refrigeration, unlike the injection which must stay between 36–46°F.
Which One Should You Choose?
Here’s a quick summary of your options.
The “needle-averse” choice: If you have a genuine phobia of injections, the Wegovy pill is a game-changer. It removes the biggest barrier to treatment without compromising on efficacy.
The “set it and forget it” choice: If you have a busy schedule and can’t commit to a 30-minute fasting window every morning, the weekly injection remains the gold standard for convenience.
If you’re ready to explore your options, a Wegovy consultation with eDrugstore will connect you with licensed providers who can help you choose the right form for your lifestyle.
Does the idea of a strict 30-minute morning wait before coffee feel like a manageable trade-off for avoiding a weekly needle?
Disclaimer: This article provides general information about health and related topics but is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
Sources
Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384:989–1002. https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
Knop FK, et al. Oral Semaglutide 50 milligram Taken Once Per Day in Adults with Overweight or Obesity (OASIS 1). Lancet. 2023. https://pubmed.ncbi.nlm.nih.gov/37385278/
Novo Nordisk. Wegovy pill approved in the US as first oral GLP-1 for weight management. December 22, 2025. https://www.novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=916472
U.S. Food and Drug Administration. Rybelsus Prescribing Information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/213051s018lbl.pdf
Buckley ST, et al. Current Understanding of SNAC as an Absorption Enhancer: The Oral Semaglutide Experience. Clinical Diabetes. 2024. https://diabetesjournals.org/clinical/article/42/1/74/153538/
Paula Clark worked in the healthcare industry for 17 years before becoming a full-time freelance health and medical writer. Her clients appreciate her ability to convey complex information in terms laypeople can understand. Paula prides herself on the depth and accuracy of her research. Her goal is to add authority to your site in words that will delight both Google and your readers.